Brand Asset Management Group, Inc. Abb Vie Inc. Transaction History

Brand Asset Management Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $103,105 - $114,865	-980 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $33,759 - $37,164	330 Added 50.77%	980 $106,000
Q4 2020 Feb 01, 2021	SELL	$80.49 - $108.67 $21,973 - $29,666	-273 Reduced 29.58%	650 $70,000
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $22,680 - $26,619	264 Added 40.06%	923 $81,000
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $5,416 - $6,511	-86 Reduced 11.54%	659 $50,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $24,221 - $28,508	-314 Reduced 29.65%	745 $60,000
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $31,139 - $38,404	400 Added 60.7%	1,059 $98,000
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $59,165 - $70,005	659 New	659 $61,000

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Brand Asset Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Brand Asset Management Group, Inc. with notifications on news.